Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
HKD 24.35
(1.46%)
HKD 24.35
(1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 634.45 Million | 231.29 Million | 342.28 Million | 262.07 Million | 348.91 Million | 391.28 Million |
| Net Income | 508.26 Million | 235.72 Million | 382.64 Million | 257.02 Million | 434.34 Million | 525.18 Million |
| Depreciation & Amortization | 197.85 Million | 204.21 Million | 162.83 Million | 132.87 Million | 115.42 Million | 83.61 Million |
| Deferred income taxes | -81.57 Million | - | - | - | - | - |
| Stock-based compensation | 14.3 Million | 30.22 Million | - | - | - | - |
| Change in working capital | 73.18 Million | -183.49 Million | 23.92 Million | 66.91 Million | -40.48 Million | -41.07 Million |
| Other non-cash items | -77.58 Million | -55.38 Million | -227.12 Million | -194.73 Million | -160.37 Million | -176.44 Million |
| Investing Cash Flow | -376.65 Million | -681.81 Million | -148.09 Million | 316.92 Million | -1.13 Billion | -794.63 Million |
| Investments in PPE | -267.23 Million | -317.14 Million | -272.09 Million | -195.86 Million | -399.3 Million | -151.87 Million |
| Acquisitions | 1.62 Million | 14.65 Million | -83.27 Million | -88.4 Million | -57.09 Million | -433.8 Million |
| Investment purchases | -204.24 Million | -528.78 Million | -696.61 Million | -273.86 Million | -1.3 Billion | -281.56 Million |
| Sales/Maturities of investments | 14.56 Million | 9.06 Million | 749.27 Million | 649.28 Million | 166.33 Million | 433.13 Million |
| Other Investing Activities | 78.63 Million | 140.4 Million | 154.61 Million | 225.76 Million | 456.78 Million | -360.53 Million |
| Financing Cash Flow | -257.72 Million | -288.35 Million | -231.25 Million | -190.06 Million | 1.39 Billion | -85.33 Million |
| Debt repayment | -16.38 Million | -47.91 Million | -95.53 Million | -49.89 Million | -79.51 Million | -42.27 Million |
| Dividends payments | -68.51 Million | -121.89 Million | -87.91 Million | -124.04 Million | -80.02 Million | -80.02 Million |
| Common Stock Repurchased | -269.97 Million | -147.67 Million | -44.9 Million | -50.95 Million | - | - |
| Common Stock Issuance | 73.68 Million | - | -3.95 Million | 84.82 Million | 1.53 Billion | - |
| Other Financing Activities | -245.72 Million | 29.12 Million | 1.05 Million | -50 Million | 13.02 Million | 36.97 Million |
| Accounts receivables | 10.13 Million | -52.33 Million | -41.92 Million | 15.63 Million | -18.87 Million | -60.1 Million |
| Accounts payables | -10.13 Million | 52.33 Million | 41.92 Million | -15.63 Million | 18.87 Million | - |
| Inventory | -48.41 Million | -138.85 Million | -28.62 Million | -18.68 Million | -27.86 Million | -23.18 Million |
| Other working capital | 111.47 Million | -44.63 Million | 52.55 Million | 85.59 Million | -12.61 Million | -17.88 Million |
| Cash at beginning of period | 559.19 Million | 1.28 Billion | 1.32 Billion | 944.5 Million | 335.62 Million | 821.88 Million |
| Cash at end of period | 569.31 Million | 559.19 Million | 1.28 Billion | 1.32 Billion | 944.5 Million | 335.62 Million |
| Capital Expenditure | -267.23 Million | -317.14 Million | -272.09 Million | -195.86 Million | -399.3 Million | -151.87 Million |
| Effect of forex changes on cash | 10.04 Million | 14.17 Million | -6.93 Million | -5.55 Million | 3.16 Million | 2.42 Million |
| Net cash flow / Change in cash | 10.12 Million | -724.69 Million | -43.99 Million | 383.38 Million | 608.88 Million | -486.26 Million |
| Free Cash Flow | 367.22 Million | -85.85 Million | 70.18 Million | 66.21 Million | -50.38 Million | 239.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 97.54 Million | 89.31 Million | 508.26 Million | 121.56 Million | 102.61 Million |
| Depreciation & Amortization | - | - | 195.38 Million | 197.85 Million | -101.77 Million | 50.88 Million |
| Deferred income taxes | - | - | -477.00 | -81.57 Million | - | - |
| Stock-based compensation | - | - | 14.67 Million | 14.3 Million | -11.82 Million | 5.91 Million |
| Change in working capital | - | - | 29.7 Million | 73.18 Million | - | - |
| Other non-cash items | - | -21.57 Million | -85.82 Million | -77.58 Million | 99.62 Million | -17.43 Million |
| Investing Cash Flow | -601.49 Thousand | 159.29 Million | 21.17 Million | -376.65 Million | -142.18 Million | -411.82 Million |
| Investments in PPE | -68.89 Million | -153.7 Million | -68.95 Million | -267.23 Million | -91.74 Million | -76.98 Million |
| Acquisitions | - | - | 1.62 Million | 1.62 Million | -499 Thousand | - |
| Investment purchases | -103.86 Million | -827.25 Million | 1.08 Billion | -204.24 Million | -1.03 Billion | -100.13 Million |
| Sales/Maturities of investments | 188.86 Million | 1.14 Billion | -1.07 Billion | 14.56 Million | 1.02 Billion | -274.22 Million |
| Other Investing Activities | -16.71 Million | 312.99 Million | 77.89 Million | 78.63 Million | -38.29 Million | -74.8 Million |
| Financing Cash Flow | -175.19 Million | 42.13 Million | -99.83 Million | -257.72 Million | -205.51 Million | 68.55 Million |
| Debt repayment | -9.28 Million | -17.84 Million | -5.76 Million | -16.38 Million | -846.88 Thousand | -35.53 Million |
| Dividends payments | - | -2.96 Million | -2.02 Million | -68.51 Million | -70.53 Million | - |
| Common Stock Repurchased | - | - | -269.97 Million | -269.97 Million | - | -10.76 Million |
| Common Stock Issuance | - | - | - | 73.68 Million | - | - |
| Other Financing Activities | 29.19 Million | 27.25 Million | 39.84 Million | -245.72 Million | -134.12 Million | 11.62 Million |
| Accounts receivables | - | - | 10.13 Million | 10.13 Million | - | - |
| Accounts payables | - | - | - | -10.13 Million | - | - |
| Inventory | - | - | -48.41 Million | -48.41 Million | - | - |
| Other working capital | - | - | 67.99 Million | 111.47 Million | - | - |
| Cash at beginning of period | 846.19 Million | 569.31 Million | 406.36 Million | 559.19 Million | 651.66 Million | 772.22 Million |
| Cash at end of period | 924.21 Million | 846.19 Million | 569.31 Million | 569.31 Million | 406.36 Million | 651.66 Million |
| Capital Expenditure | -68.89 Million | -153.7 Million | -68.95 Million | -267.23 Million | -91.74 Million | -76.98 Million |
| Effect of forex changes on cash | 1.28 Million | -524.41 Thousand | -1.26 Million | 10.04 Million | -5.2 Million | 18.67 Million |
| Net cash flow / Change in cash | 78.01 Million | 276.87 Million | 162.95 Million | 10.12 Million | -245.3 Million | -120.55 Million |
| Free Cash Flow | -68.89 Million | -77.73 Million | 173.92 Million | 367.22 Million | 15.84 Million | 64.99 Million |
PRIME
MFC-PB
JBNK
6176
603026
NUFMF